Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F3SY
|
|||
Former ID |
DIB003545
|
|||
Drug Name |
Tegafur
|
|||
Synonyms |
Tegafur (Fluoropyrimidine)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Approved | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C8H9FN2O3
|
|||
Canonical SMILES |
C1CC(OC1)N2C=C(C(=O)NC2=O)F
|
|||
InChI |
1S/C8H9FN2O3/c9-5-4-11(6-2-1-3-14-6)8(13)10-7(5)12/h4,6H,1-3H2,(H,10,12,13)
|
|||
InChIKey |
WFWLQNSHRPWKFK-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 17902-23-7
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:32188
|
Interaction between the Drug and Microbe | Top | |||
---|---|---|---|---|
The Metabolism of Drug Affected by Studied Microbe(s) | ||||
The Order in the Taxonomic Hierarchy of the following Microbe(s): Enterobacterales | ||||
Studied Microbe: Escherichia coli Nissle 1917
Show/Hide Hierarchy
|
[2] | |||
Hierarchy | ||||
Metabolic Effect | Increase activity | |||
Description | Tegafur can be metabolized by Escherichia coli Nissle 1917, which results in the increase of the drug's activity. |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 2 | Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep. 2015 Sep 29;5:14554. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.